Argan Inc (AGX)


Argan, Inc. is a U.S.-listed common stock on the NYSE under the ticker AGX. Through its subsidiaries, the company provides engineering, procurement, construction, commissioning, maintenance, project development, and technical consulting services. Its work is centered on the power generation market in the United States, the Republic of Ireland, and the United Kingdom, with projects that include biomass plants, wind farms, battery storage facilities, and solar fields. Argan also operates in industrial construction, where it supports new plant builds, expansions, maintenance turnarounds, shutdowns, emergency mobilizations, and the installation of steel components such as piping systems and pressure vessels. In addition, the company’s telecommunications infrastructure activities include underground boring, excavation, cabling, electric line work, outdoor lighting systems, and structured cabling services for government and utility customers. Argan was incorporated in 1961 and is headquartered in Arlington, Virginia.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-AGX
$347.19
-43.5% Downside
Overvalued
$679.80
10.6% Upside
Fair
Great
July 23, 2026
July 31, 2026
2
0.3%
September 3, 2026
53.4x
18.2x
8.3x
8.442 B
7.649 B
0.1%
96.7%
8.4
16.3%
301.9%
Valuation • Fair Value

Argan Inc (NYSE-AGX) Fair Value by Valuation Model

Compare the primary fair value estimate for Argan Inc (NYSE-AGX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$347.19

Estimated downside of 43.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$398.58

Discounted cash flow valuation reference.

Ben Graham Formula Value

$127.65

Classic Ben Graham valuation formula reference.

DDM Fair Value

$247.33

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$329.09

Comparable-company valuation reference.

Analyst Price Target

$679.80

Analysts imply upside of 10.6%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Argan Inc (NYSE-AGX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Argan Inc (NYSE-AGX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.042 B

Current operating scale indicator.

Revenue Forecast

1.251 B

Forward revenue estimate.

EBITDA

158.2 M

Current operating profitability reference.

EBITDA Forecast

211.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Argan Inc (NYSE-AGX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Argan Inc (NYSE-AGX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-3.73

No elevated caution signal from this screen.

Altman Z-Score

8.4

Relatively strong balance-sheet zone.

FCF / Net Income

301.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Argan Inc (NYSE-AGX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Argan Inc (NYSE-AGX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 3, 2026

Days to Earnings

44

Dividend Payment Date

July 31, 2026

Ex-Dividend Date

July 23, 2026

Dividend Yield

0.3%

Income yield reference.

Upcoming Dividend

2

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

16.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Argan Inc (NYSE-AGX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Argan Inc (NYSE-AGX) Stock Forecast & Technical Outlook

Review Argan Inc (NYSE-AGX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Argan Inc (NYSE-AGX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Argan Inc (NYSE-AGX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Argan Inc (NYSE-AGX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Argan Inc (NYSE-AGX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Argan Inc (NYSE-AGX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Argan Inc (NYSE-AGX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Argan Inc (NYSE-AGX) has a Hold consensus, with 1 buy, 3 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 3
Sell 0
FAQ Fast Investor Answers

Argan Inc (NYSE-AGX) Stock FAQ

Quick answers about Argan Inc (NYSE-AGX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$347.19
Estimated downside 43.5%
Valuation Rating
Overvalued
Estimated downside of 43.5%
Analyst Target
$679.80
Implied upside 10.6%
Financial Health
Great
Current financial-health read

The current fair value estimate for Argan Inc (NYSE-AGX) is $347.19. This implies an estimated downside of 43.5% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 43.5% versus the current market price.

The available analyst price target for Argan Inc (NYSE-AGX) is $679.80. The analyst target implies estimated upside of 10.6%.

The current financial health read for Argan Inc (NYSE-AGX) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Argan Inc (NYSE-AGX) is September 3, 2026.

Based on the current data, dividend yield is 0.3%, upcoming dividend amount is 2, ex-dividend date is July 23, 2026, payment date is July 31, 2026.

The current P/E ratio listed for Argan Inc (NYSE-AGX) is 53.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Argan Inc is 8.442 B.

The current enterprise value listed for Argan Inc is 7.649 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Argan Inc is NYSE-AGX, and the stock is listed on NYSE.

Argan Inc (NYSE-AGX) is listed on NYSE.

The current debt-to-total-capital ratio listed for Argan Inc is 0.1%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Argan Inc is 96.7%. Free float helps investors understand how much of the share base is available for public trading.